stand and de-liver, page-64

Thanks BD. Just an inquiry. This stock is definitely interesting and an enigma. It is just that some post fear info with no substance, I was always trained to look for evidence first then make determination after it is assessed. Some present questions and want answers but when questions are put back at them they do not answer.

Still the success or failure rests with Ropren sales for me not theatrics on the sidelines. Of course not you but ot6hers who I can not flame. :)